Enfermedad vascular cerebral isquémica: revisión extensa de la bibliografía para el médico de primer contacto

Q4 Medicine Medicina Interna de Mexico Pub Date : 2019-02-01 DOI:10.24245/mim.v35i1.2212
J. A. Choreño-Parra, Martha Carnalla-Cortés, Parménides Guadarrama-Ortíz
{"title":"Enfermedad vascular cerebral isquémica: revisión extensa de la bibliografía para el médico de primer contacto","authors":"J. A. Choreño-Parra, Martha Carnalla-Cortés, Parménides Guadarrama-Ortíz","doi":"10.24245/mim.v35i1.2212","DOIUrl":null,"url":null,"abstract":"Vascular cerebral ischemic disease constitutes a leading cause of morbidity and mortality as well as of disability worldwide. Its incidence has risen in developing countries in which it is estimated that two thirds of all cases occur annually. Risk factors for ischemic stroke are related with obesity and sedentary lifestyle; nonetheless, hypertension is the main factor involved in the occurrence of the disease. The prognosis depends directly on the time since the onset of the symptoms and the establishment of an optimal treatment. In recent years, important advances in the medical and interventionist treatment of ischemic stroke has been made which has resulted in a lower rate of deaths and an improvement in functionality at the short term; however, some of the therapeutic options are not available in most of the hospital centers and many patients are not eligible for endovascular procedures as they attend late or there is a delay in the identification and diagnosis of the disease. Therefore, it is of major importance that physicians and specialists taking care of patients with neurological impairment know diagnostic and therapeutic tools useful in the approach and management of ischemic stroke to improve the prognosis of the affected individuals. In this article we review the clinical approach to patients with vascular cerebral ischemic disease and make an update of the treatment with a focus on the practice of evidence-based medicine.","PeriodicalId":35750,"journal":{"name":"Medicina Interna de Mexico","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina Interna de Mexico","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24245/mim.v35i1.2212","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2

Abstract

Vascular cerebral ischemic disease constitutes a leading cause of morbidity and mortality as well as of disability worldwide. Its incidence has risen in developing countries in which it is estimated that two thirds of all cases occur annually. Risk factors for ischemic stroke are related with obesity and sedentary lifestyle; nonetheless, hypertension is the main factor involved in the occurrence of the disease. The prognosis depends directly on the time since the onset of the symptoms and the establishment of an optimal treatment. In recent years, important advances in the medical and interventionist treatment of ischemic stroke has been made which has resulted in a lower rate of deaths and an improvement in functionality at the short term; however, some of the therapeutic options are not available in most of the hospital centers and many patients are not eligible for endovascular procedures as they attend late or there is a delay in the identification and diagnosis of the disease. Therefore, it is of major importance that physicians and specialists taking care of patients with neurological impairment know diagnostic and therapeutic tools useful in the approach and management of ischemic stroke to improve the prognosis of the affected individuals. In this article we review the clinical approach to patients with vascular cerebral ischemic disease and make an update of the treatment with a focus on the practice of evidence-based medicine.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
缺血性脑血管疾病:第一接触医生的广泛文献回顾
血管性脑缺血性疾病是世界范围内发病率和死亡率以及致残率的主要原因。它在发展中国家的发病率有所上升,据估计,发展中国家每年有三分之二的病例发生。缺血性中风的危险因素与肥胖和久坐的生活方式有关;尽管如此,高血压是该疾病发生的主要因素。预后直接取决于症状出现后的时间和最佳治疗的建立。近年来,缺血性中风的医学和干预治疗取得了重要进展,在短期内降低了死亡率并改善了功能;然而,大多数医院中心都没有一些治疗选择,许多患者由于就诊较晚或疾病识别和诊断延迟,没有资格进行血管内手术。因此,重要的是,照顾神经损伤患者的医生和专家要知道在缺血性中风的治疗和管理中有用的诊断和治疗工具,以改善患者的预后。在这篇文章中,我们回顾了血管性脑缺血性疾病患者的临床治疗方法,并对治疗方法进行了更新,重点是循证医学的实践。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Medicina Interna de Mexico
Medicina Interna de Mexico Medicine-Internal Medicine
CiteScore
0.30
自引率
0.00%
发文量
137
期刊介绍: La revista Medicina Interna de México es el órgano oficial del Colegio de Medicina Interna de México Reserva de Titulo de la Dirección General del Derecho de Autor (SEP) número 04-2001-112110545900.-102 certificado de Licitud de Titulo número 11967 y Certilicado de Licitud de Contenido de la Comisión Catificadora de Publicaciones y Revistas Ilustradas (SeGob) número 8375. AutorIzada por SEPOMEX como Publicación Penódica Registro número PPO9- 0884
期刊最新文献
The evolution of pharmacological treatment of COVID-19 COVID-19, that global parenthesis Cardiovascular, hematological and renal implications of COVID-19 Acute kidney injury as a predictor of hospital discharge in COVID-19 patients Telogen effluvium and alopecia areata: Associated symptoms in patients with long COVID-19
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1